This post was originally published on this site
Piper Sandler initiated coverage on Karuna Therapeutics (NASDAQ:KRTX) with an Overweight rating and a price target of $285.00. The firm believes the company’s KarXT is poised to emerge as a valued and versatile option in a schizophrenia space that has been starved for mechanistically unique options, and further believes that peak U.S. sales approaching $3B+ are realistic.
BMO Capital initiated coverage on AstraZeneca (NASDAQ:AZN) with an Outperform rating and a price target of $82.00.
B. Riley initiated coverage on Reservoir Media Inc (NASDAQ:RSVR) with a Buy rating and a price target of $11.00. The company owns or administers over 175k publishing and recorded music copyrights, providing investors with exposure to royalties tied to irreplaceable, long-lived IP that the analysts expect to post mid-/high-single-digit organic growth.
Exane BNP Paribas initiated coverage on ManpowerGroup Inc (NYSE:MAN) with an Outperform rating and a price target of $95.00.
JPMorgan initiated coverage on Forge Global Holdings Inc (NYSE:FRGE) with a Neutral rating.
Want to get this news first? Upgrade to InvestingPro for real-time market coverage.
